Alpha-fetoprotein (AFP) is considered the most commonly used tumor marker for the identification and monitoring of HCC, but it is of low specificity and elevated also in non-cancer liver diseases such cirrhosis and chronic hepatitis [39]. Here, AFP is linked to hepatocellular carcinoma.